hCCR4/cNOT6 targets DNA-damage response proteins

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 281-291

  Sanchez Perez, I ^a   Manguan Garcia, C ^a   Menacho Marquez, M ^b   Murguia J R ^b   Perona, R ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b Universitat Politècnica de València   (Spain)

Author keywords

CCR4 CNOT complex; Chk2; Cisplatin; H2AX

Indexed keywords

ALPHA TUBULIN; ATM PROTEIN; ATR PROTEIN; BLEOMYCIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CHEMOKINE RECEPTOR CCR4; CISPLATIN; DNA DAMAGE RESPONSE PROTEIN; DNA FRAGMENT; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H2AX; HYDROXYUREA; PROTEIN CNOT6; PROTEIN HCCR4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE; GENE OVEREXPRESSION; GSE11 GENE; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CISPLATIN; DNA DAMAGE; EXORIBONUCLEASES; GENE LIBRARY; HISTONES; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; RESPONSE ELEMENTS; RNA, SMALL INTERFERING;

MAMMALIA;

EID: 57349131611     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.026     Document Type: Article

References (50)

1. Sanchez-Perez I., Martinez-Gomariz M., Williams D., Keyse S.M., and Perona R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 19 (2000) 5142-5152
2. Perona R., and Sanchez-Perez I. Signalling pathways involved in clinical responses to chemotherapy. Clin. Transl. Oncol. 9 (2007) 625-633
3. Kobayashi J., Antoccia A., Tauchi H., Matsuura S., and Komatsu K. NBS1 and its functional role in the DNA damage response. DNA Repair (Amst.) 3 (2004) 855-861
4. Pabla N., Huang S., Mi Q.S., Daniel R., and Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J. Biol. Chem. (2007)
5. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006) 402-410
6. Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
7. Lukas C., Bartkova J., Latella L., Falck J., Mailand N., Schroeder T., Sehested M., Lukas J., and Bartek J. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res. 61 (2001) 4990-4993
8. Hirao A., Cheung A., Duncan G., Girard P.M., Elia A.J., Wakeham A., Okada H., Sarkissian T., Wong J.A., Sakai T., De Stanchina E., Bristow R.G., Suda T., Lowe S.W., Jeggo P.A., Elledge S.J., and Mak T.W. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol. 22 (2002) 6521-6532
9. Jallepalli P.V., Lengauer C., Vogelstein B., and Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278 (2003) 20475-20479
10. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7 (2007) 573-584
11. Roninson I.B., Gudkov A.V., Holzmayer T.A., Kirschling D.J., Kazarov A.R., Zelnick C.R., Mazo I.A., Axenovich S., and Thimmapaya R. Genetic suppressor elements: new tools for molecular oncology - thirteenth Cornelius P. Rhoads Memorial Award Lecture. Cancer Res. 55 (1995) 4023-4028
12. Holzmayer T.A., Pestov D.G., and Roninson I.B. Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. Nucleic Acids Res. 20 (1992) 711-717
13. Gudkov A.V., Kazarov A.R., Thimmapaya R., Axenovich S.A., Mazo I.A., and Roninson I.B. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. USA 91 (1994) 3744-3748
14. Levenson V.V., Lausch E., Kirschling D.J., Broude E.V., Davidovich I.A., Libants S., Fedosova V., and Roninson I.B. A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication. Somat. Cell. Mol. Genet. 25 (1999) 9-26
15. Primiano T., Baig M., Maliyekkel A., Chang B.D., Fellars S., Sadhu J., Axenovich S.A., Holzmayer T.A., and Roninson I.B. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell 4 (2003) 41-53
16. Machado-Pinilla R., Sanchez-Perez I., Murguia J.R., Sastre L., and Perona R. A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase deficient human cells. Blood (2007)
17. Novoa I., Zeng H., Harding H.P., and Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 153 (2001) 1011-1022
18. Denis C.L. Identification of new genes involved in the regulation of yeast alcohol dehydrogenase II. Genetics 108 (1984) 833-844
19. Liu H.Y., Badarinarayana V., Audino D.C., Rappsilber J., Mann M., and Denis C.L. The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J. 17 (1998) 1096-1106
20. Liu H.Y., Chiang Y.C., Pan J., Chen J., Salvadore C., Audino D.C., Badarinarayana V., Palaniswamy V., Anderson B., and Denis C.L. Characterization of CAF4 and CAF16 reveals a functional connection between the CCR4-NOT complex and a subset of SRB proteins of the RNA polymerase II holoenzyme. J. Biol. Chem. 276 (2001) 7541-7548
21. Badarinarayana V., Chiang Y.C., and Denis C.L. Functional interaction of CCR4-NOT proteins with TATAA-binding protein (TBP) and its associated factors in yeast. Genetics 155 (2000) 1045-1054
22. Tucker M., Valencia-Sanchez M.A., Staples R.R., Chen J., Denis C.L., and Parker R. The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell 104 (2001) 377-386
23. Tucker M., Staples R.R., Valencia-Sanchez M.A., Muhlrad D., and Parker R. Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J. 21 (2002) 1427-1436
24. Chen J., Chiang Y.C., and Denis C.L. CCR4, a 3′-5′ poly(A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J. 21 (2002) 1414-1426
25. Westmoreland T.J., Marks J.R., Olson Jr. J.A., Thompson E.M., Resnick M.A., and Bennett C.B. Cell cycle progression in G1 and S phases is CCR4 dependent following ionizing radiation or replication stress in Saccharomyces cerevisiae. Eukaryoti Cell 3 (2004) 430-436
26. Traven A., Hammet A., Tenis N., Denis C.L., and Heierhorst J. Ccr4-not complex mRNA deadenylase activity contributes to DNA damage responses in Saccharomyces cerevisiae. Genetics 169 (2005) 65-75
27. 2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics 2 (2001) 9
28. Zwartjes C.G., Jayne S., van den Berg D.L., and Timmers H.T. Repression of promoter activity by CNOT2, a subunit of the transcription regulatory Ccr4-not complex. J. Biol. Chem. 279 (2004) 10848-10854
29. Morita M., Suzuki T., Nakamura T., Yokoyama K., Miyasaka T., and Yamamoto T. Depletion of mammalian CCR4b deadenylase triggers elevation of the p27Kip1 mRNA level and impairs cell growth. Mol. Cell. Biol. 27 (2007) 4980-4990
30. Collart M.A., and Timmers H.T. The eukaryotic Ccr4-not complex: a regulatory platform integrating mRNA metabolism with cellular signaling pathways?. Prog. Nucleic Acid Res. Mol. Biol. 77 (2004) 289-322
31. Garapaty S.R., Mahajan M.A., and Samuels H.H. Components of the CCR4-not complex function as nuclear hormone receptor coactivators via association with the NRC interacting factor, NIF-1. J. Biol. Chem. (2008)
32. Sanchez-Perez I., Benitah S.A., Martinez-Gomariz M., Lacal J.C., and Perona R. Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability. Mol. Biol. Cell 13 (2002) 2933-2945
33. Sanchez-Perez I., Murguia J.R., and Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16 (1998) 533-540
34. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
35. Jeyapalan J.C., Saretzki G., Leake A., Tilby M.J., and von Zglinicki T. Tumour-cell apoptosis after cisplatin treatment is not telomere dependent. Int. J. Cancer 118 (2006) 2727-2734
36. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
37. Ahn J.Y., Schwarz J.K., Piwnica-Worms H., and Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60 (2000) 5934-5936
38. Buscemi G., Savio C., Zannini L., Micciche F., Masnada D., Nakanishi M., Tauchi H., Komatsu K., Mizutani S., Khanna K., Chen P., Concannon P., Chessa L., and Delia D. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21 (2001) 5214-5222
39. Buscemi G., Carlessi L., Zannini L., Lisanti S., Fontanella E., Canevari S., and Delia D. DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues. Mol. Cell. Biol. 26 (2006) 7832-7845
40. Bennett C.B., Lewis L.K., Karthikeyan G., Lobachev K.S., Jin Y.H., Sterling J.F., Snipe J.R., and Resnick M.A. Genes required for ionizing radiation resistance in yeast. Nat. Genet. 29 (2001) 426-434
41. Hanway D., Chin J.K., Xia G., Oshiro G., Winzeler E.A., and Romesberg F.E. Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. Proc. Natl. Acad. Sci. USA 99 (2002) 10605-10610
42. Mulder K.W., Inagaki A., Cameroni E., Mousson F., Winkler G.S., De Virgilio C., Collart M.A., and Timmers H.T. Modulation of Ubc4p/Ubc5p-mediated stress responses by the RING-finger-dependent ubiquitin-protein ligase Not4p in Saccharomyces cerevisiae. Genetics 176 (2007) 181-192
43. Gros L., Delaporte C., Frey S., Decesse J., de Saint-Vincent B.R., Cavarec L., Dubart A., Gudkov A.V., and Jacquemin-Sablon A. Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents. Cancer Res. 63 (2003) 164-171
44. Gelman M.S., Ye X.K., Stull R., Suhy D., Jin L., Ng D., Than B., Ji M., Pan A., Perez P., Sun Y., Yeung P., Garcia L.M., Harte R., Lu Y., Lamar E., Tavassoli R., Kennedy S., Osborn S., Chin D.J., Meshaw K., Holzmayer T.A., Axenovich S.A., and Abo A. Identification of cell surface and secreted proteins essential for tumor cell survival using a genetic suppressor element screen. Oncogene 23 (2004) 8158-81570
45. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
46. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439
47. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald III E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
48. Mailand N., Falck J., Lukas C., Syljuasen R.G., Welcker M., Bartek J., and Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science 288 (2000) 1425-1429
49. Yu Q., Rose J.H., Zhang H., and Pommier Y. Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells. FEBS Lett. 505 (2001) 7-12
50. Stevens C., Smith L., and La Thangue N.B. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5 (2003) 401-409